Treatment Adherence in Child and Adolescent Chronic Migraine Patients

Diest, Ashley M. Kroon Van; Ramsey, Rachelle R.; Kashikar‐Zuck, Susmita; Slater, Shalonda; Hommel, Kevin A.; Kroner, John; LeCates, Susan L.; Kabbouche, Marielle A.; O’Brien, Hope L.; Kacperski, Joanne; Allen, Janelle R.; Peugh, James; Hershey, Andrew D.; Powers, Scott W.

doi:10.1097/ajp.0000000000000481

Cited by 26 publications

(10 citation statements)

References 33 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Adherence in this particular study was maximized with instructional handouts and three monthly phone contacts. In a pediatric study evaluating CBT and amitriptyline versus headache education with amitriptyline alone, adherence was evaluated with (1) a daily headache diary and (2) attendance at an in-person CBT session [20••].…”

Section: Behavioral Therapy Adherence In Headache Researchmentioning

confidence: 99%

Adherence to Behavioral Therapy for Migraine: Knowledge to Date, Mechanisms for Assessing Adherence, and Methods for Improving Adherence

Gewirtz

Minen

2019

Curr Pain Headache Rep

View full text Add to dashboard Cite

Purpose of Review In other disease states, adherence to behavioral therapies has gained attention, with a greater amount of studies discussing, defining, and optimizing adherence. For example, a meta-analysis formally discussed adherence in 25 studies of CBT for 11 different disorders, with only 6 of the 25 omitting addressing or defining adherence. Many studies have discussed the use of text messages, graph-based adherence rates, and email/telephone reminders to improve adherence. This paper examined the available literature regarding adherence to behavioral therapy for migraine as well as adherence to similar therapies in other disease states. The goal of this research is to apply lessons learned from adherence to behavioral therapy for other diseases in better understanding how we can improve adherence to behavioral therapy for migraine. Recent Findings Treatment for migraine typically includes both pharmacologic and non-pharmacologic therapies, including progressive muscle relaxation (PMR), cognitive behavioral therapy (CBT), and biofeedback. Behavioral therapies have been shown to significantly reduce headache frequency and intensity, but high attrition rates and suboptimal adherence can undermine their efficacy. Traditionally, adherence to behavioral therapy has been defined by self-report, including paper headache diaries and assignments. In person attendance has also been employed as a method of defining and monitoring adherence. With the advent of personal electronics, measurements of adherence have shifted to include electronic-based methods such as computer-based programs and mobile-based therapies. Furthermore, some studies have taken advantage of electronic methods such as email reminders, push notifications, and other mobile-based reminders to optimize adherence. The JITA-I, a novel method of engaging individual patient adherence, has also been suggested as a possible method to improve adherence by tailoring engagement with a mobile health app-based on patient input. These novel methods may be utilized in behavioral therapy for migraine for further optimizing adherence. Summary Few intervention studies to date have addressed the optimal ways to impact adherence to migraine behavioral therapy. Further research is required regarding adherence with behavioral therapies, specifically via mobile health interventions to better understand how to define and improve adherence via this novel forum. Once we are able to understand optimal methods of tracking adherence, we will be better equipped to understand the role of adherence in shaping outcomes for behavioral therapy in migraine.

show abstract

Section: Behavioral Therapy Adherence In Headache Researchmentioning

confidence: 99%

Adherence to Behavioral Therapy for Migraine: Knowledge to Date, Mechanisms for Assessing Adherence, and Methods for Improving Adherence

Gewirtz

Minen

2019

Curr Pain Headache Rep

View full text Add to dashboard Cite

show abstract

“…There are 3 main possible reasons for drop-outs: (1) some patients, who had improved, did not return to the control visit, (2) other patients, in whom the treatment had not worked, referred to other centers, and (3) adverse events related to drugs. An emerging literature demonstrates that patients with migraine and other headaches hesitate to adhere to pharmacological regimens ( 25 , 26 ). The lack of adherence to preventive therapies has significant consequences on disease severity, frequency of the attacks and social economics costs.…”

Section: Discussionmentioning

confidence: 99%

Features of Primary Chronic Headache in Children and Adolescents and Validity of Ichd 3 Criteria

et al. 2019

View full text Add to dashboard Cite

Introduction: Chronic headaches are not a rare condition in children and adolescents with negative effects on their quality of life. Our aims were to investigate the clinical features of chronic headache and usefulness of the International Classification of Headache Disorders 3rd edition (ICHD 3) criteria for the diagnosis in a cohort of pediatric patients.Methods: We retrospectively reviewed the charts of patients attending the Headache Center of Bambino Gesù Children and Insubria University Hospital during the 2010–2016 time interval. Statistical analysis was conducted to study possible correlations between: (a) chronic primary headache (CPH) and demographic data (age and sex), (b) CPH and headache qualitative features, (c) CPH and risk of medication overuse headache (MOH), and (d) CPH and response to prophylactic therapies. Moreover, we compared the diagnosis obtained by ICHD 3 vs. ICHD 2 criteriaResults: We included 377 patients with CPH (66.4% females, 33.6% males, under 18 years of age). CPH was less frequent under 6 years of age (0.8%; p < 0.05) and there was no correlation between age/sex and different CPH types. The risk to develop MOH was higher after 15 years of age (p < 0.05). When we compared the diagnosis obtained by ICHD 2 and ICHD 3 criteria we found a significant difference for the undefined diagnosis (2.6% vs. 7.9%; p < 0.05), while the diagnosis of probable chronic migraine was only possible by using the ICHD2 criteria (11.9% of patients; p < 0.05). The main criterion which was not satisfied for a definitive diagnosis was the duration of the attacks less than 2 h (70% of patients younger than 6 years; p < 0.005). Amitriptyline and topiramate were the most effective drugs (p < 0.05), although no significant difference was found between them (p > 0.05).Conclusion: The ICHD 3 criteria show limitations when applied to children under 6 years of age. The risk of developing MOH increases with age. Although our “real word” study shows that amitriptyline and topiramate are the most effective drugs regardless of the CPH type, the lack of placebo-controlled data and the limited follow-up results did not allow us to conclude about the drug efficacy.

show abstract

“…Kroon Van Diest et al [61], based on a randomized study, demonstrated the importance of Cognitive Behavioral Therapy (CBT) for adherence to pharmacological treatment and institution of lifestyle changes [62]. CBT aims, through interventions guided by a psychologist, to promote the patient's active learning in order to implement skills to deal with migraine and related conditions and situations to her.…”

Section: General and Supportive Measuresmentioning

confidence: 99%

“…Thus, during the sessions, behavioral coping skills are worked out, such as problemsolving and thought restructuring, that is, the adolescent is urged to change their ideas, beliefs, and attitudes regarding his chronic condition [62]. CBT, in combination with amitriptyline, is suggested as a first-line treatment in the context of CM in adolescents [61].…”

Section: General and Supportive Measuresmentioning

confidence: 99%

Chronic Migraine in Adolescence

Cristovam¹,

Piélak²,

Deitos³

et al. 2020

Migraine

View full text Add to dashboard Cite

Chronic migraine (CM) is a clinically and epidemiologically important disease that generates considerable impairment to those affected by it, since there is evidence of higher incidence of depression, anxiety, and chronic pain in patients with this condition. It is characterized by the occurrence of headache for at least 8 migraine days in a month and at least 15 headache days in the same month. Despite the similarity in CM presented in adults, when in adolescents it has some particularities. Thus, the aim of this chapter was to conduct a literature review, using the databases: PubMed, SciELO, and LILACS, in addition to text books, explaining the definition, epidemiology, risk factors, diagnosis, pathophysiology, treatment, and prevention of CM in adolescent population.

show abstract

Treatment Adherence in Child and Adolescent Chronic Migraine Patients

Cited by 26 publications

References 33 publications

Adherence to Behavioral Therapy for Migraine: Knowledge to Date, Mechanisms for Assessing Adherence, and Methods for Improving Adherence

Adherence to Behavioral Therapy for Migraine: Knowledge to Date, Mechanisms for Assessing Adherence, and Methods for Improving Adherence

Features of Primary Chronic Headache in Children and Adolescents and Validity of Ichd 3 Criteria

Chronic Migraine in Adolescence

Contact Info

Product

Resources

About